Showing results (281-290 of 319) with videos related to

Sort By:
Pageof 32
Gene|July 13, 2024
Integrin-α9 overexpression underlies the niche-independent maintenance of leukemia stem cells in acute myeloid leukemiaAkiko Niibori-Nambu, Chelsia Qiuxia Wang, Desmond Wai Loon Chin, et al.
Nature Communications|May 1, 2020
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationLi Ren Kong, Richard Weijie Ong, Tuan Zea Tan, et al.
Blood Cancer Journal|October 6, 2025
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)Jin Seok Kim, Yang Song, Wei-Ying Jen, et al.
Blood Advances|December 18, 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcomeHarinder Gill, Radha Raghupathy, Hsin-An Hou, et al.
JAMA Oncology|July 13, 2023
COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort StudyWei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, et al.
The Lancet. Oncology|December 17, 2015
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre studyMeletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
Cancer Cell|August 19, 2007
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myelomaJonathan J Keats, Rafael Fonseca, Marta Chesi, et al.
The Lancet. Oncology|April 4, 2017
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working GroupMichele Cavo, Evangelos Terpos, Cristina Nanni, et al.
Blood Advances|February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World AnalysisCarlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Pageof 32